<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>BioC-API</source><date /><key>BioC.key</key><document><id>2391110</id><pmcid>2391110</pmcid><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>4248</offset><text>MATERIALS AND METHODS</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4270</offset><text>Patients, samples and controls</text><annotation id="76"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4270" length="8" /><text>Patients</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4301</offset><text>Serum, pleural effusion and surgically-excised tumour tissue samples were collected from patients following written informed consent. All biospecimens were provided by the Australian Mesothelioma Tissue Bank, a member of the ABN-oncology group, which is supported by the National Health and Medical Research Council, Australia. This study was approved by the human research ethics committees of Sir Charles Gairdner and Hollywood Hospitals, Perth, Western Australia. The final diagnosis in all patients was confirmed by pathologists experienced in the diagnosis of mesothelioma and included clinical follow-up of all cases until death or to last citation in the Public Hospital database system (iSoft Clinical Manager) to confirm that the clinical pattern matched the diagnosis. Mesotheliomas were classified as epithelial, sarcomatoid, mixed or, in cases where diagnosis was made on the basis of immunocytology and there was no histological follow-up, as unspecified.</text><annotation id="77"><infon key="identifier">MESH:D003643</infon><infon key="type">Disease</infon><location offset="4930" length="5" /><text>death</text></annotation><annotation id="78"><infon key="identifier">MESH:D002292</infon><infon key="type">Disease</infon><location offset="5125" length="11" /><text>sarcomatoid</text></annotation><annotation id="79"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="4348" length="6" /><text>tumour</text></annotation><annotation id="80"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="5080" length="13" /><text>Mesotheliomas</text></annotation><annotation id="81"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="4866" length="12" /><text>mesothelioma</text></annotation><annotation id="82"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4660" length="5" /><text>human</text></annotation><annotation id="83"><infon key="identifier">MESH:D010996</infon><infon key="type">Disease</infon><location offset="4308" length="16" /><text>pleural effusion</text></annotation><annotation id="84"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4795" length="8" /><text>patients</text></annotation><annotation id="85"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4390" length="8" /><text>patients</text></annotation><annotation id="86"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="4484" length="12" /><text>Mesothelioma</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5270</offset><text>Normal mesothelial cells were recovered from pericardial fluid obtained from patients undergoing intrathoracic surgery as described previously. Serum samples were collected from healthy volunteers, and from patients with the asbestos-related lung disease, asbestosis, and the asbestos-related pleural disease, pleural plaques. Pleural effusion samples were collected from patients with effusions caused by nonmesothelioma malignancy. Effusions were classified as benign (i.e., nonmalignant) on the basis of cytological and immunohistochemical features, and further classified as exudates or transudates on the basis of Light's criteria. Effusions were classified as being associated with an infection if micro-organisms were detected in the fluid. Patient characteristics are listed in Table 1.</text><annotation id="87"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="6018" length="7" /><text>Patient</text></annotation><annotation id="88"><infon key="identifier">MESH:D010995</infon><infon key="type">Disease</infon><location offset="5563" length="15" /><text>pleural disease</text></annotation><annotation id="89"><infon key="identifier">MESH:D001195</infon><infon key="type">Disease</infon><location offset="5546" length="8" /><text>asbestos</text></annotation><annotation id="90"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="5676" length="26" /><text>nonmesothelioma malignancy</text></annotation><annotation id="91"><infon key="identifier">MESH:D010995</infon><infon key="type">Disease</infon><location offset="5580" length="15" /><text>pleural plaques</text></annotation><annotation id="92"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5347" length="8" /><text>patients</text></annotation><annotation id="93"><infon key="identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="5961" length="9" /><text>infection</text></annotation><annotation id="94"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5907" length="9" /><text>Effusions</text></annotation><annotation id="95"><infon key="identifier">MESH:D001195</infon><infon key="type">Disease</infon><location offset="5526" length="10" /><text>asbestosis</text></annotation><annotation id="96"><infon key="identifier">MESH:D001195</infon><infon key="type">Disease</infon><location offset="5495" length="8" /><text>asbestos</text></annotation><annotation id="97"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5477" length="8" /><text>patients</text></annotation><annotation id="98"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5656" length="9" /><text>effusions</text></annotation><annotation id="99"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5605" length="8" /><text>effusion</text></annotation><annotation id="100"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5704" length="9" /><text>Effusions</text></annotation><annotation id="101"><infon key="identifier">MESH:D008171</infon><infon key="type">Disease</infon><location offset="5512" length="12" /><text>lung disease</text></annotation><annotation id="102"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5642" length="8" /><text>patients</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6065</offset><text>Immunohistochemistry</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6086</offset><text>A tissue microarray was constructed by the Western Australian Research Tissue Network (Perth, Western Australia) from archival paraffin blocks. The tissue microarray contained effusion cell pellets from 20 cases of malignant mesothelioma and 16 cases of benign-reactive pleural effusions. Immunohistochemistry was performed using standard techniques. Briefly, sections were deparaffinised with xylene and rehydrated in a graded series of ethanol. Antigen-retrieval was performed for 10 min at high temperature in citrate buffer. Sections were incubated with anti-EMA clones for 60 min and washed in PBS. Immunodetection was performed using Envision+ Dual link detection system (Dako, Glostrup, Denmark). For negative controls, the primary antibody was omitted. Antibodies were purchased from various suppliers (Table 2). Some of these antibodies had been previously characterised by workshops organised by the International Society of Oncodevelopmental Biology and Medicine (ISOBM) in terms of the epitope recognised within the VNTR and whether that recognition was dependent upon the glycosylation status of the epitope. These antibodies were assigned to various classes or clusters by the ISOBM workshops based upon their staining profile on normal breast tissue samples (summarised in Table 2).</text><annotation id="103"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="6649" length="3" /><text>EMA</text></annotation><annotation id="104"><infon key="identifier">MESH:D010996</infon><infon key="type">Disease</infon><location offset="6356" length="17" /><text>pleural effusions</text></annotation><annotation id="105"><infon key="identifier">MESH:D000086002</infon><infon key="type">Disease</infon><location offset="6301" length="22" /><text>malignant mesothelioma</text></annotation><annotation id="106"><infon key="identifier">MESH:D014992</infon><infon key="type">Chemical</infon><location offset="6480" length="6" /><text>xylene</text></annotation><annotation id="107"><infon key="identifier">MESH:D000431</infon><infon key="type">Chemical</infon><location offset="6524" length="7" /><text>ethanol</text></annotation><annotation id="108"><infon key="identifier">MESH:D007854</infon><infon key="type">Chemical</infon><location offset="6685" length="3" /><text>PBS</text></annotation><annotation id="109"><infon key="identifier">MESH:D019343</infon><infon key="type">Chemical</infon><location offset="6599" length="7" /><text>citrate</text></annotation><annotation id="110"><infon key="identifier">MESH:D010232</infon><infon key="type">Chemical</infon><location offset="6213" length="8" /><text>paraffin</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7388</offset><text>Staining was assessed by three observers independently (JC, AS and GS). A positive result was defined as the presence of membranous staining on tumour cells. Staining intensity was graded semi-quantitatively as negative, equivocal (+/-), weak (1+), moderate (2+) or strong (3+). Moderate and strong positivity was only assigned where the majority of cells showed positive staining. Sensitivity was calculated as the total number of moderately and strongly stained mesothelioma samples divided by the total number of mesothelioma samples. Specificity was calculated as the number of negative benign control samples divided by the total number of benign control samples. False positive rate was calculated as the number of moderately and strongly stained benign samples divided by the total number of benign samples.</text><annotation id="111"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="7852" length="12" /><text>mesothelioma</text></annotation><annotation id="112"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="7904" length="12" /><text>mesothelioma</text></annotation><annotation id="113"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="7532" length="6" /><text>tumour</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8205</offset><text>Quantitative PCR</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8222</offset><text>RNA was extracted using Rneasy kits (Qiagen, Clifton Hill, Victoria, Australia), following the manufacturer's protocol. cDNA was generated in a standard reverse transcriptase reaction using oligo dT to prime Superscript II (Invitrogen, Mt Waverly, Victoria, Australia). Quantitative PCR was performed with specific primer sets (MUC1 forward 5'-AGACGTCAGCGTGAGTGATG-3'; reverse 5'-GACAGCCAAGGCAATGAGAT-3') on the iCycler iQ Real Time Detection System (BioRad, Gladesville, New South Wales, Australia) using the QuantiTech SYBR Green PCR Kit (Qiagen). The primers correspond to nucleotides 4757-5017 of the human polymorphic epithelial mucin gene (GeneBank Accession number M61170) and amplify the MUC1-TM product. The relative expression of MUC1-TM was calculated using the standard delta Ct formula as follows: </text><annotation id="114"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="8550" length="4" /><text>MUC1</text></annotation><annotation id="115"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="8827" length="5" /><text>human</text></annotation><annotation id="116"><infon key="identifier">MESH:C098022</infon><infon key="type">Chemical</infon><location offset="8743" length="10" /><text>SYBR Green</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9044</offset><text>Fish</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9049</offset><text>4 mum sections from the tissue microarray were deparaffinised, dehydrated, microwave treated in citrate buffer (pH 6.0) for 10 min, digested in pepsin solution (4 mg ml-1 in 0.01N HCl) for 7 min at 37 C, rinsed in 0.3 M sodium chloride, 30 mM sodium citrate (pH 7.0) at room temperature for 5 min. Dual-probe hybridisation was performed using three SpectrumGreen-labeled BAC clones which encompass the MUC1 gene at 1q22, plus a SpectrumOrange-labeled chromosome 1 centromeric probe (Vysis, Downers Grove, IL, USA) as a control. Seventeen mesothelioma samples were available for FISH analysis.</text><annotation id="117"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9451" length="4" /><text>MUC1</text></annotation><annotation id="118"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="9587" length="12" /><text>mesothelioma</text></annotation><annotation id="119"><infon key="identifier">MESH:D012965</infon><infon key="type">Chemical</infon><location offset="9269" length="15" /><text>sodium chloride</text></annotation><annotation id="120"><infon key="identifier">MESH:D019343</infon><infon key="type">Chemical</infon><location offset="9145" length="7" /><text>citrate</text></annotation><annotation id="121"><infon key="identifier">MESH:D000077559</infon><infon key="type">Chemical</infon><location offset="9292" length="14" /><text>sodium citrate</text></annotation><annotation id="122"><infon key="identifier">MESH:D006851</infon><infon key="type">Chemical</infon><location offset="9229" length="3" /><text>HCl</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9661</offset><text>Conventional PCR</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9678</offset><text>Conventional PCR was performed with specific primer sets designed for different splice forms as described by and using Taq DNA polymerase (Qiagen). The primer pair Muc1-F (GCACTCACCATAGCACG) and Muc1-R (GGCCAGAGTCAATTGTAC) distinguish between MUC1-TM and a secreted MUC1 isoform, containing the VNTR but lacking the transmembrane domain and cytoplasmic tail, MUC1/secreted (SEC). PCR products were separated by electrophoresis on 3.5% agarose gel and visualised under UV light with ethidium bromide.</text><annotation id="123"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9873" length="5" /><text>Muc1-</text></annotation><annotation id="124"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9921" length="4" /><text>MUC1</text></annotation><annotation id="125"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9944" length="4" /><text>MUC1</text></annotation><annotation id="126"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="10037" length="4" /><text>MUC1</text></annotation><annotation id="127"><infon key="identifier">MESH:D012685</infon><infon key="type">Chemical</infon><location offset="10113" length="7" /><text>agarose</text></annotation><annotation id="128"><infon key="identifier">MESH:D004996</infon><infon key="type">Chemical</infon><location offset="10160" length="16" /><text>ethidium bromide</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10178</offset><text>Measurement of CA15-3</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10200</offset><text>CA15-3 levels were determined using the IMMULITE 2000 BR-MA (CA15-3) assay (Diagnostic Products Corporation, Los Angeles, CA, USA) according to the manufacturer's instructions. The assay is a sandwich ELISA utilising the monoclonal antibodies 115D8 and DF3. A value above 53 kU l-1 was considered to be outside the normal range of healthy persons. All assays were performed on coded samples by technical staff unaware of the patient's diagnosis.</text><annotation id="129"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="10200" length="6" /><text>CA15-3</text></annotation><annotation id="130"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="10261" length="6" /><text>CA15-3</text></annotation><annotation id="131"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10625" length="7" /><text>patient</text></annotation></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10652</offset><text>Statistics</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10663</offset><text>To test for statistically significant differences biomarkers were transformed to the logarithmic scale on which normal theory statistical estimates (mean, s.d.) and tests (t-tests) were applied.</text></passage><annotation id="76"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4270" length="8" /><text>Patients</text></annotation><annotation id="77"><infon key="identifier">MESH:D003643</infon><infon key="type">Disease</infon><location offset="4930" length="5" /><text>death</text></annotation><annotation id="78"><infon key="identifier">MESH:D002292</infon><infon key="type">Disease</infon><location offset="5125" length="11" /><text>sarcomatoid</text></annotation><annotation id="79"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="4348" length="6" /><text>tumour</text></annotation><annotation id="80"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="5080" length="13" /><text>Mesotheliomas</text></annotation><annotation id="81"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="4866" length="12" /><text>mesothelioma</text></annotation><annotation id="82"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4660" length="5" /><text>human</text></annotation><annotation id="83"><infon key="identifier">MESH:D010996</infon><infon key="type">Disease</infon><location offset="4308" length="16" /><text>pleural effusion</text></annotation><annotation id="84"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4795" length="8" /><text>patients</text></annotation><annotation id="85"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="4390" length="8" /><text>patients</text></annotation><annotation id="86"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="4484" length="12" /><text>Mesothelioma</text></annotation><annotation id="87"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="6018" length="7" /><text>Patient</text></annotation><annotation id="88"><infon key="identifier">MESH:D010995</infon><infon key="type">Disease</infon><location offset="5563" length="15" /><text>pleural disease</text></annotation><annotation id="89"><infon key="identifier">MESH:D001195</infon><infon key="type">Disease</infon><location offset="5546" length="8" /><text>asbestos</text></annotation><annotation id="90"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="5676" length="26" /><text>nonmesothelioma malignancy</text></annotation><annotation id="91"><infon key="identifier">MESH:D010995</infon><infon key="type">Disease</infon><location offset="5580" length="15" /><text>pleural plaques</text></annotation><annotation id="92"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5347" length="8" /><text>patients</text></annotation><annotation id="93"><infon key="identifier">MESH:D007239</infon><infon key="type">Disease</infon><location offset="5961" length="9" /><text>infection</text></annotation><annotation id="94"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5907" length="9" /><text>Effusions</text></annotation><annotation id="95"><infon key="identifier">MESH:D001195</infon><infon key="type">Disease</infon><location offset="5526" length="10" /><text>asbestosis</text></annotation><annotation id="96"><infon key="identifier">MESH:D001195</infon><infon key="type">Disease</infon><location offset="5495" length="8" /><text>asbestos</text></annotation><annotation id="97"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5477" length="8" /><text>patients</text></annotation><annotation id="98"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5656" length="9" /><text>effusions</text></annotation><annotation id="99"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5605" length="8" /><text>effusion</text></annotation><annotation id="100"><infon key="identifier">MESH:D000080324</infon><infon key="type">Disease</infon><location offset="5704" length="9" /><text>Effusions</text></annotation><annotation id="101"><infon key="identifier">MESH:D008171</infon><infon key="type">Disease</infon><location offset="5512" length="12" /><text>lung disease</text></annotation><annotation id="102"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="5642" length="8" /><text>patients</text></annotation><annotation id="103"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="6649" length="3" /><text>EMA</text></annotation><annotation id="104"><infon key="identifier">MESH:D010996</infon><infon key="type">Disease</infon><location offset="6356" length="17" /><text>pleural effusions</text></annotation><annotation id="105"><infon key="identifier">MESH:D000086002</infon><infon key="type">Disease</infon><location offset="6301" length="22" /><text>malignant mesothelioma</text></annotation><annotation id="106"><infon key="identifier">MESH:D014992</infon><infon key="type">Chemical</infon><location offset="6480" length="6" /><text>xylene</text></annotation><annotation id="107"><infon key="identifier">MESH:D000431</infon><infon key="type">Chemical</infon><location offset="6524" length="7" /><text>ethanol</text></annotation><annotation id="108"><infon key="identifier">MESH:D007854</infon><infon key="type">Chemical</infon><location offset="6685" length="3" /><text>PBS</text></annotation><annotation id="109"><infon key="identifier">MESH:D019343</infon><infon key="type">Chemical</infon><location offset="6599" length="7" /><text>citrate</text></annotation><annotation id="110"><infon key="identifier">MESH:D010232</infon><infon key="type">Chemical</infon><location offset="6213" length="8" /><text>paraffin</text></annotation><annotation id="111"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="7852" length="12" /><text>mesothelioma</text></annotation><annotation id="112"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="7904" length="12" /><text>mesothelioma</text></annotation><annotation id="113"><infon key="identifier">MESH:D009369</infon><infon key="type">Disease</infon><location offset="7532" length="6" /><text>tumour</text></annotation><annotation id="114"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="8550" length="4" /><text>MUC1</text></annotation><annotation id="115"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="8827" length="5" /><text>human</text></annotation><annotation id="116"><infon key="identifier">MESH:C098022</infon><infon key="type">Chemical</infon><location offset="8743" length="10" /><text>SYBR Green</text></annotation><annotation id="117"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9451" length="4" /><text>MUC1</text></annotation><annotation id="118"><infon key="identifier">MESH:D008654</infon><infon key="type">Disease</infon><location offset="9587" length="12" /><text>mesothelioma</text></annotation><annotation id="119"><infon key="identifier">MESH:D012965</infon><infon key="type">Chemical</infon><location offset="9269" length="15" /><text>sodium chloride</text></annotation><annotation id="120"><infon key="identifier">MESH:D019343</infon><infon key="type">Chemical</infon><location offset="9145" length="7" /><text>citrate</text></annotation><annotation id="121"><infon key="identifier">MESH:D000077559</infon><infon key="type">Chemical</infon><location offset="9292" length="14" /><text>sodium citrate</text></annotation><annotation id="122"><infon key="identifier">MESH:D006851</infon><infon key="type">Chemical</infon><location offset="9229" length="3" /><text>HCl</text></annotation><annotation id="123"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9873" length="5" /><text>Muc1-</text></annotation><annotation id="124"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9921" length="4" /><text>MUC1</text></annotation><annotation id="125"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="9944" length="4" /><text>MUC1</text></annotation><annotation id="126"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="10037" length="4" /><text>MUC1</text></annotation><annotation id="127"><infon key="identifier">MESH:D012685</infon><infon key="type">Chemical</infon><location offset="10113" length="7" /><text>agarose</text></annotation><annotation id="128"><infon key="identifier">MESH:D004996</infon><infon key="type">Chemical</infon><location offset="10160" length="16" /><text>ethidium bromide</text></annotation><annotation id="129"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="10200" length="6" /><text>CA15-3</text></annotation><annotation id="130"><infon key="identifier">4582</infon><infon key="type">Gene</infon><infon key="NCBI Homologene">136477</infon><location offset="10261" length="6" /><text>CA15-3</text></annotation><annotation id="131"><infon key="identifier">9606</infon><infon key="type">Species</infon><location offset="10625" length="7" /><text>patient</text></annotation></document></collection>